VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Jun 8, 2026
Document Date
Jun 4, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
MCGUIRE DANIEL PATRICK
Copyright © 2005-2026 Vanda Pharmaceuticals Inc. |